NEVVI Medicare utilization intelligence
or

← back

Provider profile

MINTER, STEVEN D.O.

Hematology-Oncology · NPI 1649431990 · COLUMBIA, SC

2
Groups
84
Codes · 2024
242,453
Disclosed services

MINTER, STEVEN is a Hematology-Oncology in COLUMBIA, SC, a member of 2 medical groups, who billed 84 distinct codes to Medicare Part B in 2024.

Groups: MUSC COMMUNITY PHYSICIANS (ORANGEBURG, SC) · SOUTH CAROLINA ONCOLOGY ASSOC PA (COLUMBIA, SC) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

242,453
disclosed services
84
codes billed to Medicare Part B
Prior year · CY2023 162,007 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0897 Injection, denosumab, 1 mg
J0185 Injection, aprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9263 Injection, oxaliplatin, 0.5 mg
J1627 Injection, granisetron, extended-release, 0.1 mg
J9271 Injection, pembrolizumab, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
A9585 Injection, gadobutrol, 0.1 ml
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J9267 Injection, paclitaxel, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80048 Blood test, basic group of blood chemicals (calcium, total)
80076 Liver function blood test panel
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
J9190 Injection, fluorouracil, 500 mg
96372 Injection of drug or substance under skin or into muscle
96361 Infusion into a vein for hydration, each additional hour
82784 Gammaglobulin (immune system protein) measurement
J2469 Injection, palonosetron hcl, 25 mcg
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J2919 Injection, methylprednisolone sodium succinate, 5 mg
96413 Administration of chemotherapy into vein, 1 hour or less
Q5122 Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
82728 Ferritin (blood protein) level
85044 Red blood count, manual test
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
83540 Iron level
83550 Iron binding capacity
96375 Injection of additional new drug or substance into vein
83615 Lactate dehydrogenase (enzyme) level
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
71260 Ct scan of chest with contrast
96415 Administration of chemotherapy into vein, each additional hour
J9045 Injection, carboplatin, 50 mg
82607 Cyanocobalamin (vitamin b-12) level
74177 Ct scan of abdomen and pelvis with contrast
82746 Folic acid level, serum
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96411 Administration of additional new drug or substance into vein using push technique
J3489 Injection, zoledronic acid, 1 mg
84153 Psa (prostate specific antigen) measurement, total
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3490 Unclassified drugs
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96360 Infusion into a vein for hydration, 31-60 minutes
84443 Blood test, thyroid stimulating hormone (tsh)
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
82378 Carcinoembryonic antigen (cea) protein level
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
J7060 5% dextrose/water (500 ml = 1 unit)
71250 Ct scan of chest without contrast
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
77080 Dxa bone density measurement of hip, pelvis, spine
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
70553 Mri scan of brain before and after contrast
71046 X-ray of chest, 2 views
80053 Blood test, comprehensive group of blood chemicals
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
74183 Mri scan of abdomen before and after contrast
77075 Complete x-ray of body bones
74176 Ct scan of abdomen and pelvis without contrast
81015 Urinalysis using microscope
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
74160 Ct scan of abdomen with contrast
78816 Nuclear medicine study whole body with ct scan
96523 Irrigation of implanted venous access drug delivery device
38222 Biopsy and aspiration of bone marrow sample for diagnosis

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.